“…Nevertheless, the delineation of the EZ using HFO (Frauscher et al, 2017;Thomschewski et al, 2019) has proven to be highly predictive of seizure outcome (Fedele et al, 2017b,c,d;Boran et al, 2019b;Chen et al, 2021;Dimakopoulos et al, 2021) and therefore, may improve the outcome of epilepsy surgery. Moreover, an accumulation of recent evidence suggests that HFO are also measurable by non-invasive scalp EEG (Andrade-Valenca et al, 2011;Boran et al, 2019c;Kuhnke et al, 2019;van Klink et al, 2019;Cserpan et al, 2021aCserpan et al, , 2022aTamilia et al, 2021;Noorlag et al, 2022). Therefore HFO are investigated as potential biomarkers to delineate the EZ but also to monitor disease severity and treatment response (Fan et al, 2020;Jacobs and Zijlmans, 2020).…”